Evaluating the prognostic potential of telomerase signature in breast cancer through advanced machine learning model.

Journal: Frontiers in immunology
Published Date:

Abstract

BACKGROUND: Breast cancer prognosis remains a significant challenge due to the disease's molecular heterogeneity and complexity. Accurate predictive models are critical for improving patient outcomes and tailoring personalized therapies.

Authors

  • Xiao Guo
    School of Pharmacy, Beihua University, Jilin, China.
  • Yuyan Cao
    School of Pharmacy, Beihua University, Jilin, China.
  • Xinlin Shi
    School of Pharmacy, Beihua University, Jilin, Jilin, China.
  • Jiaying Xing
    School of Pharmacy, Beihua University, Jilin, China.
  • Chuanbo Feng
    School of Pharmacy, Beihua University, Jilin, China.
  • Tao Wang
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.